Evidence map›Paper›PMID 22133317›Full record

ReviewThe Journal of allergy and clinical immunology2011

Asthma exacerbations: origin, effect, and prevention.

David J Jackson, Annemarie Sykes, Patrick Mallia, Sebastian L Johnston

2 registry-linked trialsAbstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 143 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03513458 phase1 / phase2withdrawnnot on this mapstarted 2020, after this paper: background citation

Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2020 to 2021Enrolled0ConditionsAsthmaArmsAnakinra, Anakinra Matching Placebo, Dermatophagoides Farinae
NCT03513471 phase1 / phase2withdrawnnot on this mapstarted 2019, after this paper: background citation

Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2021Enrolled0ConditionsAsthmaArmsAnakinra, Anakinra Matching Placebo, Dermatophagoides Farinae
3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Management of asthma exacerbations in the paediatric population: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2021
    Pooled it
  3. Pooled it
  4. Antibiotics for exacerbations of asthma.The Cochrane database of systematic reviews · 2018
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. CompEx Asthma: is it time for a change in clinical trials?The European respiratory journal · 2025
    Article
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David J JacksonNational Heart and Lung Institute, Imperial College London, London, United Kingdom.
Annemarie Sykes
Patrick Mallia
Sebastian L Johnston

Funding

Medical Research Council G0601236Medical Research Council G0700552Medical Research Council G1000758Wellcome Trust
6 · The paper itself

Abstract

Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resources. Respiratory tract viruses have emerged as the most frequent triggers for exacerbations in both children and adults; however, the mechanisms underlying these remain poorly understood. More recently, it has become increasingly clear that interactions might exist between viruses and other triggers, increasing the likelihood of an exacerbation. In this article we begin with an overview of the health, economic, and social burden that exacerbations of asthma carry with them. This is followed by a review of the pathogenesis of asthma exacerbations, highlighting the various triggers responsible and multiple interactions that exist between them. The final section first addresses what preventative measures are currently available for asthma exacerbations and subsequently examines which of the new treatments in development might lessen the burden of exacerbations in the future.

Indexed as

AsthmaHumansRespiratory Tract Infections

Identifiers

PMID22133317
PMCPMC7172902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.